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ABSTRACT 
 
 Vitamin A plays an important role in growth, vision, epithelial differentiation, immune 
function, and reproduction.  However, vitamin A metabolites like retinoic acid (RA) pose many 
toxic effects in the body.  Certain retinoid drugs like N-(4-hydroxyphenyl)retinamide (4-HPR) 
have shown promise treating epithelial cancers.  Further research into the nonhydrolyzable 
analog, 4-hydroxybenzylretinone (4-HBR), have determined that it is just as potent but without 
any of the residual toxicity associated with RA.  A new synthetic method for this drug was 
created, using a para-methyl benzyl phenyl ether as protecting group for the terminal phenol.  
Synthetic efficiency was also increased by the development of a larger scale synthesis for the 
expensive starting retinoid, retinal.  This new method can successfully synthesize 4-HBR at a 
lower cost with good yields.  This is useful for future chemical and biological studies of the 
retinoid.   
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I. INTRODUCTION 
 
 Vitamin A is an essential lipid-soluble component found in certain foods.  In the human 
body, vitamin A plays an important role in growth, vision, epithelial differentiation, immune 
function, and reproduction1.  The most common forms are retinol and retinyl esters.  Retinol can 
be reversibly converted in the body to the vitamin A aldehyde form, retinal, the chemical basis of 
vision in animals. The aldehyde form can be further oxidized, irreversibly, to retinoic acid 
(Figure 1).  Retinoic acid (RA) is important for cell growth and development, and is also toxic at 
high levels. Toxic effects include mucocutaneous irritation, night blindness, hyperlipidemia, 
headache, bone loss, and other developmental effects2.  RA affects epithelial cells through 
nuclear receptor proteins, which resulted in the use of retinoids as drugs for epithelial cancers 
and dermatological diseases2. 
 
 Figure 1: Vitamin A metabolism 
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 Retinoids act, pharmacologically, to restore the regulation of differentiation and growth 
in malignant cells3. One drug thought to act in a RA-like manner is N-(4-
hydroxyphenyl)retinamide (4-HPR; 1).  4-HPR has been shown to induce apoptosis in a variety 
of cancer cell lines, including, breast, prostate, and leukemia4.  Though similar to RA, 4-HPR is 
considerably less teratogenic, and consequently less toxic. However, 4-HPR has been shown to 
cause reversible ocular toxicity in human clinical trials.  It has been determined that 4-HPR does 
not interact with the same nuclear receptor proteins as RA, and it is suggested that the toxic 
effects of 4-HPR may be a result of in vivo hydrolysis to RA5. This has led to interest in 
developing other synthetic retinoid analogs that address issues of toxicity. 
 
Figure 2: 4-HPR (1) and 4-HBR (2) 
 
 4-hydroxybenzylretinone (4-HBR; 2) is a carbon-linked, nonhydrolyzable analogue of 4-
HPR.  The ketone, 4-HBR, like its amide analogue, has been shown to induce apoptosis and cell 
death in breast cancer cells3.  4-HPR and 4-HBR were compared in a study of mammary tumor 
growth in rats.  The control animals had an average increase in tumor volume of 179% compared 
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with a decrease of 42% and 45% of rats treated with 4-HPR and 4-HBR, respectively3. An 
important difference between the two retinoids is, however, that 4-HBR is not hydrolyzed in vivo 
to liberate RA.  This eliminates any residual RA-induced toxicity of 4-HBR, specifically the 
ocular toxicity associated with 4-HPR.  4-HBR therefore provides the ability to decrease tumor 
cell concentrations, while remaining less toxic at pharmacologically effective doses. In fact, 
researchers have determined that 4-HBR can be administered at doses nearly twice as high as 4-
HPR without adverse teratogenic effects (unpublished results).  It is now important to develop an 
efficient synthesis of 4-HBR for continued research related to its biochemical activity and 
effects. 
 
 
II. DISCUSSION of Syntheses and Procedures 
 
 The necessity of 4-HBR for related chemical and biochemical studies has also led the 
desire for a more efficient synthetic route.  The established procedure involves expensive starting 
materials and often produced 4-HBR in low yields.  The umpolung synthesis began by activating 
retinal for reaction with trimethylsilyl cyanide, and then alkylating a suitable benzyl halide5. 
Silyl protecting groups were used both for the ketone and phenol during the reaction6.   These 
protecting groups were removed with tetra-n-butylammonium fluoride (TBAF) with 65% yield.   
The original umpolung 4-HBR synthesis scheme is depicted in Figure 3. 
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Figure 3: Original 4-HBR synthesis6 
 
 The focus of this work has been to increase synthetic efficiency, both by reducing cost 
and increasing reaction yields.    
 
 
2.1 Retinal Synthesis Improvements and Applications 
 
 Vitamin A aldehyde is the retinoid used as the starting molecule for the 4-HBR synthesis.  
It is available commercially, however it is very expensive (~$200/g)7.  It was therefore important 
to develop an efficient synthesis of this molecule on a reasonbly large scale (Figure 4).  A retinal 
synthesis7 was recently reported that starts from retinyl acetate, which is available at low cost 
(<$5/g) because of its production as a vitamin supplement. This synthesis proceeded with 
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transesterification of the acetate ester with methanol followed by oxidation of the obtained 
retinol upon passage through a column of MnO2/diatomaceous earth. Although the yields were 
good, about 8% of the retinal obtained was the 13-cis isomer, which required careful 
chromatographic removal to give a solid product. It has been determined that the scaling of this 
oxidation column to handle greater than about 1 g of retinyl acetate results in a column of 
unwieldy proportions and slows elution of retinal sufficiently to result in a significant increase in 
the formation of side-products and in a reduction in yields.  
 
 
 
 
 
 
 
 
 
 
 As previously reported, stirring retinyl acetate in a dilute anhydrous methanolic solution 
with one equivalent of sodium metal completes transesterification to retinol in forty minutes. We 
now recommend no volume reduction of the resulting solution before passage through an ion-
exchange resin (Amberlite IRA-400, chloride form) to give a quantitative yield of the base labile 
retinol, which is used as obtained.   The oxidation of retinol can be completed much more 
quickly (4.5-5.0 hours compared to 12-24 hours) when stirred in dry ethyl acetate with MnO2 (25 
Figure 4: Retinal synthesis scheme 
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eq).  This synthetic route has been scaled up to 5 g of starting material with yields as good as 
85% and also produced less 13-cis isomerization (only 2%, Figure 5).  If desired, further 
purification can now be conducted by flash column chromatography on silica gel (5% ethyl 
acetate/hexane then 10% ethyl acetate/hexane).   
At 40 times lower cost than of 
commercial retinal, this synthesis8 can 
quickly produce larger quantities of the 
vitamin A aldehyde to be used in other 
synthetic reactions or for biological 
applications.   
 
 
2.2 Benzyl Ether Protecting 
Group: Synthesis and 
Performance 
 
 Previous 4-HBR syntheses have 
relied on silyl ether protecting groups for 
both the aldehyde and the phenol group.   
Reactions yields were low, and often 
were associated with multiple side 
products.  One significant side product 
formed during the benzyl alkylation and 
deprotection steps was the synthesis of a 
terminal benzyl phenyl ether (BPE; Figure 5:  HPLC trace of retinal showing the major 
all-trans product and the minor cis isomers 
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Figure 6).  The side product appeared to be due to O-alkylation of 4-HBR by residual benzylic 
bromide6.  Investigation into alternate protecting groups suggested that a benzyl group could be 
used to protect the terminal phenol.  A reaction scheme that targeted the molecule that was once 
a significant side product was thought to increase yields, specifically at the alkylation and 
deprotection steps of the synthesis. 
 
 Figure 6: 4-HBR side product from alkylation and deprotection steps. 
 
 Trimethylsilyl iodide	   (TMSI) can be used to cleave ethers to their corresponding 
alcohols, however prolonged exposure to the reagent can lead to the formation of iodide 
products11.  It was therefore important to determine the best benzyl protecting group in terms of 
rate of cleavage.  There has not been substantial research on how substituted benzyl ethers affect 
cleavage rates.  Two substituted BPEs were synthesized, along with the commercially available 
unsubstituted BPE, to determine the effect of electron donating and withdrawing groups on 
subsequent cleavage reactions.  The decision was made to use weak electron withdrawing and 
weak electron donating groups because of the concern that TMSI may react more favorably with 
a stronger side chain (either donating or withdrawing), which would reduce cleavage yields. An 
un-substituted ether was used as a control molecule, and a para-methyl and a para-chloro group 
as weak electron donating and withdrawing groups, respectively (Figure 7).   
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Figure 7: From left to right: BPE, para-methyl BPE, and para-chloro BPE. 
 
 The synthesized benzyl phenyl ethers were cleaved with TMSI and monitored for phenol 
production with an analytical high performance liquid chromatography (HPLC) method.  A 
concern over whether the TMSI byproducts (I2 and/or HI) would react with the polyene chain of 
the target retinoid (2) led to the inclusion of cyclohexene (10 eq) in the cleavage reaction 
scheme. Cyclohexene was also included in the comparative BPE cleavage reactions. 
Cyclohexene was used as a  “dummy” electron rich double bond to intercept traces of HI or 
iodine in the reaction mixture, with the hope of reducing any acid-catalyzed or iodine-induced 
isomerization of the retinoid product.  Reaction samples were taken at 10, 30, and 100 minutes, 
quenched with methanol and monitored at the maximum absorbance wavelength for phenol (270 
nm)10.  It was suspected that an electron-donating group would lead to greater reactivity and 
ether cleavage.  This was the case, as the para-methyl BPE cleaved significantly faster than the 
other BPEs.  The results for cleavage of the three benzyl phenyl ethers are shown in Figure 8. 
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 Figure 8: Phenol formation from cleavage of substituted BPEs 
 
 The much faster cleavage rate of the para-methyl BPE made it a logical choice for a 
benzyl protecting group because it would expose the product to TMSI for less time.  The para-
methyl BPE would become the group that would be connected via an alkylation reaction to the 
activated form of retinal.   
 
 
2.3 Umpolung Synthesis of Protected 4-HBR 
 The synthesis of 4-HBR is based on alkylating a protected phenol group by the terminal 
end of retinal.  The retinal must first be made more reactive; stirring with tert-butyldimethylsilyl 
cyanide protects both the carbonyl oxygen and attaches a cyano group to the carbonyl carbon.  
This dipole reversal results in an acidic hydrogen on the terminal end (Figure 9).   
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Figure 9: Retinal activation; carbonyl protection and dipole reversal.   
 The acidic hydrogen is removed with lithium hexamethyldisilazane (similar to Figure 3), 
and the protected phenol group (as a benzyl bromide; Figure 10) can be added.  The bromide 
form of para-methyl BPE is synthesized from an aldehyde9 via an alcohol intermediate13 (Figure 
10). 
 
Figure 10: BPE protecting group reaction scheme 
 
 A portion of pure 4-HBR was used to attach the para-methyl BPE for comparison.  The 
product structure (Figure 11) was confirmed by NMR and was used as a reference for the 
deprotection products. 
 
 
2.4 Deprotection 
 
 The deprotection of 4-HBR involved two steps: removing the tert-butyldimethylsilyl 
(TBS) and cyano groups and removing the benzyl group.  A portion of protected 4-HBR was 
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examined by first removing the TBS group.  After one day stirring with tetra-n-butylammonium 
fluoride (TBAF), the product was successfully converted to the ketone form of protected 4-HBR 
(Figure 11).   This targeted product is very similar to the prominent side product in the original 
reaction scheme (Figure 6).  The product was then subjected to TMSI in an attempt to cleave the 
benzyl group.   
 
Figure 11: Benzyl protected, post-TBAF 4-HBR ketone. 
 
 As adapted from Kadota et al., TMSI/Et3N was first used in attempt to cleave the benzyl 
protecting group to the phenyl alcohol.  Extended reaction times were required because of the 
chemical environment of the retinoid, and minimal reaction progress was noted.  The product 
was then treated in a variety of chemical scenarios.  The reactions were first run without 
cyclohexene, to address the possibility that this was slowing cleavage rates, at room temperature.  
Reaction samples were quenched and assayed in a similar method to the BPE cleavage 
comparisons (quenched with MeOH at 30, 60, and 90 minutes).  The HPLC (85% 
methanol/water at 350 nm) was compared to that of pure 4-HBR.  The HPLC results confirmed 
product synthesis, starting as early as the 30-minute mark (Figure 12).  This suggests that TMSI 
can in fact cleave the protected retinoid to yield 4-HBR. 
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Figure 12: HPLC trace comparing pure 4-HBR (top) to the 30-minute 
TMSI cleavage product.  4-HBR retention time at 22.8 min. 
 
 
2.5 4-HBR Synthesis Improvements 
 
 This project has successfully synthesized or isolated the following products: retinal, BPE, 
4-methyl BPE, 4-chloro BPE, 4-(4-methylbenzyoxy)benzaldehyde, 4-(4-methylbenzyoxy)benzyl 
alcohol, 4-(4-methylbenzyoxy)benzyl bromide, activated retinal, protected 4-HBR, protected 4-
HBR ketone.  All products were used in the development of a new synthetic scheme for 4-HBR. 
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 The overall cost of synthesis was greatly reduced by the retinal improvements.  As the 
base retionoid for the 4-HBR synthesis, retinal is the most essential starting material.  The 
synthetic developments to retinal have not only decreased its cost 40-fold, but also increased 
efficiency (85% yields) and product purity (98% all-trans). 
 Yields in the 4-HBR reaction scheme have been comparable to the previous synthesis6.  
However, the new synthesis addresses the most significant side product formed.  Fine-tuning of 
the deprotection steps can make this step far more efficient than the established synthesis.  
Furthermore, the products synthesized in the new method have shown good molecular and 
isomer purity. 
 
2.6 Future Directions 
 
 Continued investigation of potential phenol protecting groups could help futher improve 
the 4-HBR synthesis.  Kadota et al. suggests that methoxyphenyl methyl (MPM) ethers can be 
selectively cleaved with TMSI/Et3N.  Investigation into the applications of an MPM ether 
protecting group on 4-HBR could illuminate an alternate synthetic route.  However, the initial 
concerns of this type of chemical environment must be addressed.  Although the literature 
suggests selective cleavage of MPM ethers, the presence of a methoxy ether may require 
additional equivalents of TMSI.   Any excess of this reactant may lead to isomerization of the 
product retinoid, either from HI or iodine.   
 Additionally, there is not much known about the biological targets of 4-HBR.  Studies 
have shown that 4-HBR binds poorly to the retinoic acid receptors (RAR) α, β, and γ 5.  The 
affinity for these receptors is similar to that of 4-HPR, however as discussed, 4-HBR cannot 
hydrolyze to liberate RA.  A possible study could examine which cellular proteins interact with 
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4-HBR.  A specially designed affinity gel containing 4-HPR/4-HBR could be used to identify 
binding proteins to the drug and provide important insights to its cellular metabolism.  This may 
illuminate the chemotherapeutic mechanisms of these retinoid pharmaceuticals. 
 
 
III. EXPERIMENTAL 
 
All reagents were purchased as reagent grade from Sigma-Aldrich (Milwaukee, WI) and were 
used as obtained. Reactions were performed in oven-dried glassware under an argon atmosphere 
and gold fluorescent lights. Analytical TLC was performed on silica gel 60 F254 aluminum-
backed plates from Merck (Darmstadt, Germany). Flash column chromatography was performed 
on silica gel 60 (230-400 mesh) from Merck. Analysis by HPLC was done on a Beckman 
Instruments unit (model 127 pump, model 166 detector) using 1 mL/min of MeOH-H2O through 
a Polaris C18 column. 1H and 13C NMR spectra were recorded in CDCl3 on a Bruker Instruments 
DRX400 spectrometer (Billerica, MA) operating at 400 MHz for 1H measurements. Electrospray 
mass spectra were measured on a Micromass QTOF mass spectrometer in the Ohio State 
University Campus Chemical Instrument Center. 
 
Retinal 
 
To a stirred solution of retinyl acetate (5.10 g; 15.5 mmol) in 500 mL of anhydrous methanol 
was added sodium pieces (0.39 g; 1.1 eq.) and the mixture stirred for 40 minutes at which time 
TLC (20% ethyl acetate/hexane) indicated complete consumption of retinyl acetate. The solution 
was passed through Amberlite IRA-400 ion-exchange resin (6.5 g; chloride form) and the 
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column rinsed with methanol. The eluent was concentrated under reduced pressure to a red oil 
which was dissolved in the minimum amount of dry dichloromethane (2-3 mL). After addition of 
activated MnO2 (33 g; 24.4 eq.) and dry ethyl acetate (40 ml), the thick suspension was stirred 
for 5 hr. at which time TLC indicated complete oxidation to retinal. The product solution was 
filtered through a pad of diatomaceous earth with dichloromethane rinsing and the filtrate was 
evaporated to give solid yellow-orange retinal; (3.75 g; 85% yield): mp 57.5-60 oC; HPLC: tR = 
10.3 min (~96%). 1H NMR (CDCl3): δ 0.93 (s, 6H, CMe2), 1.36 (m, 2H, CH2), 1.51 (m, 2H, 
CH2), 1.61 (s, 3H, CH3), 1.90 (m, 2H, CH2), 1.91 (s, 3H, CH3), 2.20 (s, 3H, CH3), 5.83 (d, 1H, J 
= 8 Hz, 14-CH), 6.03-6.25 (m, 4H, vinyls), 7.03 (dd, 1H, J = 11.6 and 14.9 Hz, 12-CH), 9.97 (d, 
1H, J = 8 Hz, CHO). 13C NMR (CDCl3): δ 13.6, 13.7, 19.9, 22.4, 29.7, 33.8, 34.9, 40.3, 129.7, 
130.19, 130.21, 130.96, 133.1, 135.3, 137.8, 138.3, 141.7, 155.1, 191.3. HRMS (ESI): m/z [M + 
Na]+ : Calcd for C20H28O + Na: 307.2038. Found: 307.2040. 
 
4-chloro benzyl phenyl ether 
 
Phenol (0.1016 g, 1.08 mmol) and cesium carbonate (0.69 g, 2 eq.) were dissolved in 40 mL 
acetonitrile.  para-Chlorobenzyl chloride ( 0.85 g, 5.3 eq.) was added and the mixture was stirred 
at reflux for 5 hr.  Solvent was evaporated and organic product extracted in ether from water (3 x 
50 mL).  The product was washed with brine, dried over MgSO4, filtered and concentrated under 
reduced pressure to yield 4-chloro benzyl phenyl ether as a white solid (19.5 mg, 8.25 %).  1H 
NMR (CDCl3): δ 5.02 (s, 2H, CH2), 6.93-7.35 (m, 9H, Ar). 
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4-methyl benzyl phenyl ether 
 
 
Phenol (0.1002 g, 1.06 mmol) and cesium carbonate (0.47 g, 1.5 eq.) were dissolved in 40 mL 
acetonitrile. 4-methylbenzyl chloride (0.70 mL, 0.75 g, 5.3 eq.) was added and the mixture was 
stirred at reflux for 5 hr.  Solvent was evaporated and organic product extracted in ether from 
water (3 x 50 mL).  The product was washed with brine, dried over MgSO4, filtered and 
concentrated under reduced pressure to yield 4-methyl benzyl phenyl ether as a white solid (7.5 
mg, 4.0 %).  1H NMR (CDCl3): δ 2.36 (s, 3H, CH3), 5.02 (s, 2H, CH2), 6.96-7.34 (m, 9H, Ar). 
 
Benzyl phenyl ether Cleavage 
 
Benzyl phenyl ether (7.04 mg, 0.038 mmol) and cyclohexene (25 mg, 8 eq) were combined in 
dichloromethane (25 mL).  Trimethylsilyl iodide (19.1 mg, 2.5 eq) was added and the reaction 
mixture was stirred at room temperature.  At 10, 30, and 100 min., reaction progress was 
monitored by removing 2 mL of reaction mixture and quenching with MeOH (2 mL).  The 
quenched product was analyzed on by HPLC (70% methanol/water) at 270 nm.  The absorbances 
were compared to a standard phenol curve to determine product concentration. 
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4-chloro benzyl phenyl ether Cleavage 
 
4-Chloro benzyl phenyl ether (8.3 mg, 0.038 mmol) and cyclohexene (25 mg, 8 eq) were 
combined in dichloromethane (25 mL).  Trimethylsilyl iodide (19.1 mg, 2.5 eq) was added and 
the reaction mixture was stirred at room temperature.  At 10, 30, and 100 min., reaction progress 
was monitored by removing 2 mL of reaction mixture and quenching with MeOH (2 mL).  The 
quenched product was analyzed on by HPLC (70% methanol/water) at 270 nm.  The absorbances 
were compared to a standard phenol curve to determine product concentration. 
 
4-methyl benzyl phenyl ether Cleavage 
 
4-Methyl benzyl phenyl ether (7.5 mg, 0.038 mmol) and cyclohexene (25 mg, 8 eq) were 
combined in dichloromethane (25 mL).  Trimethylsilyl iodide (19.1 mg, 2.5 eq) was added and 
the reaction mixture was stirred at room temperature.  At 10, 30, and 100 min., reaction progress 
was monitored by removing 2 mL of reaction mixture and quenching with MeOH (2 mL).  The 
quenched product was analyzed on by HPLC (70% methanol/water) at 270 nm.  The absorbances 
were compared to a standard phenol curve to determine product concentration. 
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4-(4-Methylbenzyloxy)benzaldehyde 
 
 
4-Hydroxybenzaldehyde (6.60 g, 54.0 mmol) and 4-methylbenzylchloride (5.0 g, 35.6 mmol) 
were added to a stirred solution of Cs2CO3 (23.14 g, 71.0 mmol) in 100 mL dry acetonitrile.  The 
mixture was stirred at reflux for 48 hr.  Solvent was evaporated under air overnight and the 
product was extracted into ether from 1 M NaOH and washed with brine.  The organic layer was 
filtered, dried with MgSO4, then evaporated under reduced pressure to yield the crude 4-(4-
methylbenzyloxy)benzaldehyde as a white solid (7.8712 g, 97%).  1H NMR (CDCl3): δ 2.34 (s, 
3H, CH3), 5.07 (s, 2H, CH2), 7.02-7.30 (m, 8H, Ar), 9.84 (s, 1H, CHO). HRMS (ESI): m/z [M + 
Na]+ : Calcd for C15H14O2 + Na: 249.0891. Found: 249.0883. 
 
4-(4-Methylbenzyloxy)benzyl aclohol 
 
4-(4-Methylbenzyloxy)benzaldehyde (3.87 g, 17.1 mmol) was dissolved in anhydrous ethanol 
containing sodium borohydride (1.31 g, 2 eq.).  The reaction mixture was stirred at r.t. for 90 
min. and then quenched with saturated ammonium chloride solution (15 mL).  The organic 
product was then extracted into ethyl acetate from water (3 x 100 mL).  The product was washed 
with brine and dried over MgSO4, and solvent was evaporated under reduced pressure.  Column 
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chromatographic purification (20% ethyl actetate/hexane then 40% ethyl acetate/hexane) yielded 
4-(4-methylbenzyloxy)benzyl alcohol as a white solid (2.92 g, 74.7%).  1H NMR (CDCl3): δ 2.34 
(s, 3H, CH3), 4.595 (brd, 2H, CH2OH, J= 2.03 Hz), 5.01 (s, 2H, CH2), 6.93-7.31 (m, 8H, Ar).  
13C NMR (CDCl3): δ 21.95, 65.86, 70.77, 115.74, 116.02, 127.63, 128.33, 129.34, 130.03, 
134.67, 138.51.  HRMS (ESI): m/z [M + Na]+ : Calcd for C15H16O2 + Na: 251.1048. Found: 
251.1051. 
 
4-(4-Methylbenzyloxy)benzyl bromide
 
4-(4-Methylbenzyloxy)benzyl alcohol (0.99 g, 4.34 mmol) and pyridine (.08 mL) were dissolved 
in 15 mL of Et2O and cooled to 0 °C.  PBr3 (1.29 g, 0.45 mL, 4.78 mmol) was added in 10 mL of 
Et2O over 30 min.  The reaction mixture was then stirred at r.t. for 90 min.  The organic product 
was extracted into ether from ice/brine mixture.  The organic layer was washed with saturated 
NaHCO3, brine, and dried over MgSO4.  The solution was filtered and evaporated under reduced 
pressure to give 4-(4-methylbenzyloxy)benzyl bromide as a white solid (1.06 g, 83.8 %) which 
was used as obtained. 1H NMR (CDCl3): δ 2.34 (s, 3H, CH3), 4.47 (s, 2H, CH2), 4.99 (s, 2H, 
CH2), 6.89-7.29 (m, 8H, Ar). 13C NMR (CDCl3): δ 21.95, 34.68, 70.82, 115.90, 116.12, 128.34,  
130.11, 130.88, 131.20, 134.44, 138.63.   
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Retinal Activation 
 
Retinal (1.0 g, 3.5 mmol) was combined with tert-butyldimethylsilyl cyanide (1.76 g, 12.7 
mmol) and triethylamine (0.2 mL, 1.27 mmol) in dry dichloromethane.  The reaction mixture 
was stirred at r.t. for 2 days.  TLC (20% ethyl acetate/hexane) confirmed reaction completion, 
and the sample was purified via column chromatography (5% ethyl acetate/hexane).  The solvent 
was evaporated under reduced pressure to give activated retinal as a red semisolid (1.41 g, 94%) 
which was used as soon as possible in the next reaction.  
 
Alkylation 
 
Activated retinal (1.41 g, 3.31 mmol) was dissolved in 20 mL dry THF and cooled to -78 °C.  
Lithium hexamethyldisilazane (1 M in THF, 5.0 mL) was added and the mixture was stirred for 
30 min. 4-(4-Methylbenzyloxy)benzyl bromide (1.05 g, 1.1 eq) was added in dry THF (20 mL) 
and reaction was stirred at -78 °C for 1.75 hr.  The reaction was warmed to r.t. as stirred for 15 
min, and then was quenched with saturated NH4Cl (10 mL) and H2O (10 mL).  Organic product 
was extracted into ethyl acetate from water (3 x 200 mL) and washed with brine.  The organic 
layer was dried over Na2SO4, filtered and concentrated to give crude product as a red semisolid.  
Column chromatography (2.5% ethyl acetate/hexane) yielded pure product as a yellow-orange 
crystalline solid (650 mg, 31 %). 1H NMR (CDCl3): δ 0.08 (s, 3H, CH3), 0.11 (s, 3H, CH3), 0.85 
(s, 9H, CH3), 1.01 (s, 6H, CH3), 1.44-1.46 (m, 2H, CH2), 1.55 (s, 3H, CH3), 1.58-1.66 (m, 2H, 
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CH2), 1.69 (s, 3H, CH3), 1.95 (s, 3H, CH3), 2.00 (m, 2H, CH2), 2.34 (s, 3H, CH3), 3.06 (d, 2H, 
CH2) 4.99 (s, 2H, CH2), 5.38 (s, 1H, 14-CH), 6.06-6.17 (m, 4H, vinyls), 6.65 (dd, 1H, J = 11.4 
and 11.3 Hz, 11-CH), 6.88 (d, 2H, J = 8.5 Hz, Ar), 7.15-7.18 (m, 4H, Ar), 7.29 (d, 2H, J = 7.9 
Hz, Ar).  HRMS (ESI): m/z [M + Na]+ : Calcd for C42H57O2SiN + Na: 658.4056. Found: 
658.4033. 
 
Silyl Deprotection  
 
 
Protected 4-HBR (50 mg, 0.079 mmol) was stirred with tetra-n-butylammonium fluoride (22.6 
mg, 1.0 eq) in 90% THF/water overnight.  TLC (20% ethyl acetate/hexanes) confirmed reaction 
completion and after volume reduction the product was extracted into ethyl acetate from water.  
The organic layer was washed with brine and dried over MgSO4.  Preparative TLC (20% ethyl 
acetate/hexanes) was used to provide pure 4-methylbenzyl protected 4-HBR as a yellow 
crystalline solid (12 mg, 31%).  1H NMR (CDCl3): δ 1.02 (s, 6H, CMe2), 1.45-1.48 (m, 2H, 
CH2), 1.60-1.63 (m, 2H, CH2), 1.71 (s, 3H, CH3), 1.98 (s, 3H, CH3), 2.02 (m, 2H, CH2), 2.32 (s, 
3H, CH3), 2.34 (s, 3H, CH3), 3.66 (s, 2H, CH2), 4.99 (s, 2H, CH2), 6.11-6.31 (m, 5H, vinyls), 
7.03 (dd, 1H, J = 11.4 and 11.5 Hz, 11-CH), 6.92 (d, 2H, J = 8.4 Hz, Ar), 7.12 (d, 2H, J = 8.4 
Hz, Ar), 7.17 (d, 2H, J = 7.8 Hz, Ar), 7.30 (d, 2H, J = 7.8 Hz, Ar).  13C NMR (CDCl3): δ 13.71, 
15.04, 20.00, 21.96, 22.52, 29.74, 33.91, 35.05, 40.40, 51.70, 70.75, 115.85, 125.77, 128.18, 
128.38, 129.76, 130.02, 130.39, 130.90, 131.23, 133.16, 134.81, 136.40, 138.02, 138.46, 138.49, 
140.76, 153.08, 158.62, 199.42.  HRMS (ESI): m/z [M + Na]+ : Calcd for C35H42O2 + Na: 
517.3083. Found: 517.3077. 
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Benzyl Deprotection  
 
4-Methylbenzyl protected 4-HBR (13 mg, 0.026 mmol) was stirred with trimethylsilyl iodide (10 
µL, 2.7 eq) in dichloromethane at r.t.  At 30, 60, and 90 min., reaction progress was monitored 
by removing 10 µL of reaction mixture and quenching with MeOH (50 µL)).  The quenched 
product was analyzed by HPLC (85% methanol/water) at 350 nm.  The product retention time 
was compared to that of pure 4-hydroxybenzylretinone to confirm the formation of the product 
retinoid. HPLC: tR = 22.8 min. 
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APPENDIX 
 
 
Plot of phenol standard solutions used for TMSI cleavage reaction assay. 
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1H NMR Spectra 
 
 
 
Mass Spec Data 
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Mass Spectra  
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